Advertisement

Relation of Monocyte Number to Progression of Aortic Stenosis

      Rapid progression of aortic stenosis (AS) is associated with poor prognosis. However, the relation between monocyte number and AS progression is unknown. Here, we detected the relation between monocyte number and AS progression. We retrospectively analyzed 220 patients with AS with at least 2 echocardiograms with the maximal interval ≥180 days from January 2016 to June 2021. AS severity was categorized by aortic jet velocity (Vmax) and mean pressure gradient. Rapid progression of AS was defined when Vmax increased ≥0.3 m/s/year. Patients were divided into low and high monocyte groups according to the cut-off value of the receiver-operating characteristic curve. AS progression was compared between the 2 groups. Various models of binary logistic regression were used to reveal the association between monocyte number and rapid progression. During a median of 601 days of echocardiographic follow-up (interquartile range 353 to 909), 52.7% of the population was in rapid progression. Patients in the high monocyte group had more rapid progression in both Vmax and mean pressure gradient (p = 0.020 and p = 0.030, respectively). The percentage of patients with severe AS was increased by 5.4% in the low monocyte group and 16.9% in the high monocyte group. Different models of binary logistic regression showed that the monocyte number was positively associated with the rapid progression. In conclusion, a higher monocyte number was associated with the rapid progression of AS.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosenhek R
        • Binder T
        • Porenta G
        • Lang I
        • Christ G
        • Schemper M
        • Maurer G
        • Baumgartner H.
        Predictors of outcome in severe, asymptomatic aortic stenosis.
        N Engl J Med. 2000; 343: 611-617
        • Nistri S
        • Faggiano P
        • Olivotto I
        • Papesso B
        • Bordonali T
        • Vescovo G
        • Dei Cas L
        • Cecchi F
        • Bonow RO
        Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care.
        Am J Cardiol. 2012; 109: 718-723
      1. Mateos N, Gómez M, Homar A, Garcia-Elias A, Yáñez L, Tajes M, Molina L, Ble M, Cladellas M, Roqueta C, Benito B. Plasmatic PCSK9 levels are associated with very fast progression of asymptomatic degenerative aortic stenosis [published online August 2, 2021]. J Cardiovasc Transl Res doi:10.1007/s12265-021-10138-4.

        • Otto CM
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        • O'Gara PT
        • Rigolin VH
        • Sundt TM
        • Thompson A
        • Toly C
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        Circulation. 2021; 143: e35-e71
        • Baumgartner H
        • Falk V
        • Bax JJ
        • De Bonis M
        • Hamm C
        • Holm PJ
        • Iung B
        • Lancellotti P
        • Lansac E
        • D Rodriguez Muñoz
        • Rosenhek R
        • Sjögren J
        • P Tornos Mas
        • Vahanian A
        • Walther T
        • Wendler O
        • Windecker S
        • JL Zamorano
        • ESC Scientific Document Group
        2017 ESC/EACTS Guidelines for the management of valvular heart disease.
        Eur Heart J. 2017; 38: 2739-2791
        • Li G
        • Qiao W
        • Zhang W
        • Li F
        • Shi J
        • Dong N.
        The shift of macrophages toward M1 phenotype promotes aortic valvular calcification.
        J Thorac Cardiovasc Surg. 2017; 153 (e1): 1318-1327
        • Yang LT
        • Boler A
        • Medina-Inojosa JR
        • Scott CG
        • Maurer MJ
        • Eleid MF
        • Enriquez-Sarano M
        • Tribouilloy C
        • Michelena HI.
        Aortic stenosis progression, cardiac damage, and survival: comparison between bicuspid and tricuspid aortic valves.
        JACC Cardiovasc Imaging. 2021; 14: 1113-1126
        • Otto CM
        • Kuusisto J
        • Reichenbach DD
        • Gown AM
        • O'Brien KD
        Characterization of the early lesion of “degenerative” valvular aortic stenosis. Histological and immunohistochemical studies.
        Circulation. 1994; 90: 844-853
        • Cho KI
        • Sakuma I
        • Sohn IS
        • Jo SH
        • Koh KK.
        Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
        Atherosclerosis. 2018; 277: 60-65
        • Zhang P
        • The E
        • Nedumaran B
        • Ao L
        • Jarrett MJ
        • Xu D
        • Fullerton DA
        • Meng X
        Monocytes enhance the inflammatory response to TLR2 stimulation in aortic valve interstitial cells through paracrine up-regulation of TLR2 level.
        Int J Biol Sci. 2020; 16: 3062-3074
        • Shimoni S
        • Meledin V
        • Bar I
        • Fabricant J
        • Gandelman G
        • George J.
        Circulating CD14(+) monocytes in patients with aortic stenosis.
        J Geriatr Cardiol. 2016; 13: 81-87
        • Baratchi S
        • Zaldivia MTK
        • Wallert M
        • Loseff-Silver J
        • Al-Aryahi S
        • Zamani J
        • Thurgood P
        • Salim A
        • Htun NM
        • Stub D
        • Vahidi P
        • Duffy SJ
        • Walton A
        • Nguyen TH
        • Jaworowski A
        • Khoshmanesh K
        • Peter K
        Transcatheter aortic valve implantation represents an anti-inflammatory therapy via reduction of shear stress-induced, piezo-1-mediated monocyte activation.
        Circulation. 2020; 142: 1092-1105
        • Hewing B
        • Au SC
        • Ludwig A
        • Ellerbroek R
        • van Dijck P
        • Hartmann L
        • Grubitzsch H
        • Giannini C
        • Laule M
        • Stangl V
        • Baumann G
        • Stangl K.
        Severe aortic valve stenosis in adults is associated with increased levels of circulating intermediate monocytes.
        J Cardiovasc Transl Res. 2017; 10: 27-34
        • Hewing B
        • Ellerbroek R
        • Au SC
        • Stangl V
        • Dreger H
        • Laule M
        • Grubitzsch H
        • Knebel F
        • Baumann G
        • Ludwig A
        • Stangl K.
        Levels of circulating intermediate monocytes decrease after aortic valve replacement in patients with severe aortic stenosis.
        Thromb Haemost. 2017; 117: 2346-2355
        • Akahori H
        • Tsujino T
        • Naito Y
        • Matsumoto M
        • Lee-Kawabata M
        • Ohyanagi M
        • Mitsuno M
        • Miyamoto Y
        • Daimon T
        • Hao H
        • Hirota S
        • Masuyama T.
        Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis.
        Eur Heart J. 2011; 32: 888-896
        • Akahori H
        • Tsujino T
        • Naito Y
        • Yoshida C
        • Lee-Kawabata M
        • Ohyanagi M
        • Mitsuno M
        • Miyamoto Y
        • Daimon T
        • Masuyama T.
        Intraleaflet haemorrhage as a mechanism of rapid progression of stenosis in bicuspid aortic valve.
        Int J Cardiol. 2013; 167: 514-518
        • Diehl P
        • Nagy F
        • Sossong V
        • Helbing T
        • Beyersdorf F
        • Olschewski M
        • Bode C
        • Moser M.
        Increased levels of circulating microparticles in patients with severe aortic valve stenosis.
        Thromb Haemost. 2008; 99: 711-719
        • Dimitrow PP
        • Jawień M.
        Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia.
        Pharmacol Rep. 2010; 62: 1250-1254
        • França CN
        • Izar MCO
        • Hortêncio MNS
        • do Amaral JB
        • Ferreira CES
        • Tuleta ID
        • Fonseca FAH.
        Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
        Clin Sci (Lond). 2017; 131: 1215-1224
        • Van Craenenbroeck AH
        • Van Ackeren K
        • Hoymans VY
        • Roeykens J
        • Verpooten GA
        • Vrints CJ
        • Couttenye MM
        • Van Craenenbroeck EM.
        Acute exercise-induced response of monocyte subtypes in chronic heart and renal failure.
        Mediators Inflam. 2014; 2014216534
        • Ganjali S
        • Gotto Jr, AM
        • Ruscica M
        • Atkin SL
        • Butler AE
        • Banach M
        • Sahebkar A.
        Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases.
        J Cell Physiol. 2018; 233: 9237-9246
        • Kuwana M
        • Okazaki Y
        • Kodama H
        • Izumi K
        • Yasuoka H
        • Ogawa Y
        • Kawakami Y
        • Ikeda Y.
        Human circulating CD14 + monocytes as a source of progenitors that exhibit mesenchymal cell differentiation.
        J Leukoc Biol. 2003; 74: 833-845
        • Egan KP
        • Kim JH
        • Mohler 3rd, ER
        • Pignolo RJ.
        Role for circulating osteogenic precursor cells in aortic valvular disease.
        Arterioscler Thromb Vasc Biol. 2011; 31: 2965-2971
        • Sucosky P
        • Balachandran K
        • Elhammali A
        • Jo H
        • Yoganathan AP.
        Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF- beta1-dependent pathway.
        Arterioscler Thromb Vasc Biol. 2009; 29: 254-260
        • Pardali E
        • Makowski LM
        • Leffers M
        • Borgscheiper A
        • Waltenberger J.
        BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation.
        J Cell Mol Med. 2018; 22: 5429-5438
        • Han YP
        • Tuan TL
        • Wu H
        • Hughes M
        • Garner WL.
        TNF- alpha stimulates activation of pro-MMP2 in human skin through NF- (kappa)B mediated induction of MT1-MMP.
        J Cell Sci. 2001; 114: 131-139